search

Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) have succeeded in turning human stem cells from skin samples into “tiny, three-dimensional, brain-like cultures”. 

The LCSB, part of the University of Luxembourg, said the cultures behaved “very similarly” to cells in the human midbrain.

They said they had succeeded in getting various cell types to develop, connect, exchange signals and “produce metabolic products typical of the active brain”.

Professor Jens Schwamborn, in whose research group the work was done, said: “Our cell cultures open new doors to brain research. “We can now use them to study the causes of Parkinson’s disease and how it could possibly be effectively treated.”

The human “midbrain” – particularly the structure known as the substantia nigra – is of great interest in the fight against Parkinson’s. Researchers are unable to remove cells from this region of the brain for study due to ethical concerns. But the work done at the LCSB may help researchers to resolve this problem.

 

Read more

“An international view on the European healthtech market”

08-04-2024

Carole Brückler at the Luxembourg Ministry of the Economy speaks about why companies should attend the European Digital Healthtech Conference on 14-15 May 2024.
Read more

56 days until the 2024 European Digital HealthTech Conference

19-03-2024

Register for a unique conference exploring the challenges of bringing health technologies to the market and their solutions from 14 to 15 May 2024 in Luxembourg. A call for speakers is also open until 16 April.
Read more

Science-VC partnership spurs Luxembourg healthtech innovation

28-02-2024

The Luxembourg Institute of Health and Catalpa Ventures will support digital health innovation by bridging scientific research and venture capital.
Read more

Breaking data barriers: Dynaccurate’s healthtech innovation journey in Luxembourg

28-01-2024

Dynaccurate’s technology harmonises data using artificial intelligence. Applications for the technology are vast, especially in health and life sciences. All sectors where precise meaning is necessary can benefit, and this can include defence, law and engineering to name a few. CEO Dermot Doyle talks about how the company innovates in Luxembourg, which provides many possibilities for research partnerships.
Read more

Digital twins in healthcare: MDSIM’s innovative approach

23-01-2024

Luxembourg healthtech start-up MDSIM is revolutionising the way surgeries are planned and executed. Benefitting from the country’s support for innovative R&D, data infrastructure and partnerships within the local ecosystem, it does this by harnessing the power of computer modelling and simulation, data sciences and artificial intelligence to unlock new horizons in patient care.
Read more

All news

Close